| Peer-Reviewed

Headache in Hemangioblastomas: A Histopathology and Structural

Received: 13 November 2022    Accepted: 31 January 2023    Published: 6 July 2023
Views:       Downloads:
Abstract

Background: To determine the efficacy of treatment of central nervous system (CNS) hemangioblastomas in von Hippel-Lindau disease (VHL), long-term outcomes in patients with hemangioblastoma and VHL variant were accepted. Hemangioblastoma is rare, histological origin. Highly vascularized tumors that can be found throughout the neuraxis but are mainly located in the cerebellum and in the spinal cord. The most common primary tumor of the posterior fossa in adults. Hemangioblastomas may also occur within the spine. Material and Methods: This meta-analysis was performed to evaluate headaches in Hemangioblastoma (HBL) tumors structurally and separately based on randomized controlled trial studies. Electronic databases (PubMed, MEDLINE, Embase, and Cochrane Library) were searched for randomized and controlled trial studies that searched for the results of treatment of brain tumors (Hemangioblastoma type) and headache in Hemangioblastoma (HBL) tumors. Result: This meta-analysis was performed using Review Manager (Rev Man) software (version 5.2) provided by Cochrane Collaboration. The data used were hazard ratios with 95% confidence intervals calculated for time-to-event data extracted from survival curves and local tumor control rate curves. A consecutive series of patients with hemangioblastomas on between 2010 and 2020 by the senior author (A. AN) is Reviewed. Conclusion: Adequate knowledge of the treatment and correct use of microsurgical techniques allows complete resection of these tumors with minimal complications and maximum functional improvement. The result appears to be directly related to the preoperative condition.

Published in Pharmaceutical Science and Technology (Volume 7, Issue 1)
DOI 10.11648/j.pst.20230701.12
Page(s) 5-12
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Hemangioblastoma, Vascularized Tumor, Primary Tumor, Von Hippel-Lindau, Neuraxis

References
[1] Burger PC and Scheithauer BW: Tumors of the central nervous system. In: Atlas of Tumor Pathology. 3rd series, Kandel ER and Schwartz JH (eds), pp 381-384, Armed Forces Institute of Pathology, Washing DC, 1994.
[2] Neumann HP and Wiestler OD: Clustering of features of von Hippel - Lindau syndrome - evidence for a complex genetic locus -. Lancet 337: 1052-1054, 1991.
[3] Bohling T et al: von Hippel-Lindau disease and capillary haemangioblastoma. Pathology and genetics of tumours of the nervous system. Kleihues P and Cavenee WK, pp 223-226, World Health Organization International Agency for Research on Cancer, Lyon, 2000.
[4] Matsumoto K and Kannuki S: Hemangioblastoma and von Hippel - Lindau disease. Nippon Rinsho 53: 2672-2677, 1995.
[5] Constans JP et al: Posterior fossa hemangioblastomas. Surg Neurol 25: 269-275, 1986.
[6] Elster AD and Arthur DW: Intracranial hemangioblastomas -CT and MR findings-J Comput Assist Tomogr 12: 736-739, 1988.
[7] Latif F et al: Identification of the von Hippel - Lindau diaease tumor suppressor gene. Science 260: 1317-1320, 1993.
[8] Chang SD, Meisel JA, Hancock SL, Martin DP, McManus M, Adler JR Jr: Treatment of hemangioblastomas in von Hippel - Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43: 28–35, 1998.
[9] Cristante L, Herrmann HD: Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir (Wien) 141: 333–340, 1999.
[10] Joaquim AF, Santos MJ, Tedeschi H: [Surgical management of intramedullary hemangioblastomas.] Coluna/Columna 8: 274–278, 2009 (Portuguese).
[11] Melmon KL, Rosen SW: Lindau’s disease: Review of the literature and study of a large kindred. Am J Med 36: 595–617, 1964.
[12] Browne TR, Adams RD, Roberson GH: Hemangioblastoma of the spinal cord: Review and report of five cases. Arch Neurol 33: 435–441, 1976.
[13] Gläsker S, Bender BU, Apel TW, Natt E, Van Velthoven V, Scheremet R, Zentner J, Neumann HP: The impact of molecular genetic analysis of the VHL gene in patients with hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 67: 758–762, 1999.
[14] Ho VB, Smirniotopoulos JG, Murphy FM, Rushing EJ: Radiologic-pathologic correlation: Hemangioblastoma. AJNR Am J Neuroradiol 13: 1343–1352, 1992.
[15] Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55: 898–901, 1992.
[16] Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P: Hemangioblastomas of the central nervous system: A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70: 24–30, 1989.
[17] Berlis A, Schumacher M, Spreer J, Neumann HP, Van Velthoven V: Subarachnoid hemorrhage due to cervical spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease. Acta Neurochir (Wien) 145: 1009– 1013, 2003.
[18] Cerejo A, Vaz R, Feyo PB, Cruz C: Spinal cord hemangioblastoma with subarachnoid hemorrhage. Neurosurgery 27: 991–993, 1990.
[19] Cervoni L, Franco C, Celli P, Fortuna A: Spinal tumors and subarachnoid hemorrhage: Pathogenetic and diagnostic aspects in 5 cases. Neurosurg Rev 18: 159–162, 1995.
[20] Djindjian M, Djindjian R, Houdart R, Hurth M: Subarachnoid hemorrhage due to intraspinal tumors. Surg Neurol 9: 223–229, 1978.
[21] Irie K, Kuyama H, Nagao S: Spinal cord hemangioblastoma presenting with subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 38: 355–358, 1998.
[22] Kormos RL, Tucker WS, Bilbao JM, Gladstone RM, Bass AG: Subarachnoid hemorrhage due to a spinal cord hemangioblastoma: Case report. Neurosurgery 6: 657–660, 1980.
[23] Minami M, Hanakita J, Suwa H, Suzui H, Fujita K, Nakamura T: Cervical hemangioblastoma with a past history of subarachnoid hemorrhage. Surg Neurol 49: 278–281, 1998.
[24] Adegbite AB, Rozdilsky B, Varughese G: Supratentorial capillary hemangioblastoma presenting with fatal spontaneous intracerebral hemorrhage. Neurosurgery 12: 327–330, 1983.
[25] Kikuchi K, Kowada M, Sasaki J, Yanagida N: Cerebellar hemangioblastoma associated with fatal intratumoral hemorrhage: Report of an autopsied case [in Japanese]. No Shinkei Geka 22: 593–597, 1994.
[26] Yu JS, Short MP, Schumacher J, Chapman PH, Harsh GR: Intramedullary hemorrhage in spinal cord hemangioblastoma: Report of two cases J Neurosurg 81: 937–940, 1994.
[27] Choyke, et al. von Hippel-Lindau disease: genetic, clinical and imaging features. Radiology. 1995; 194: 629–642.
[28] Ho VB, et al. Radiologic-Pathologic correlation: hemangioblastoma. AJNR Am J Neuroradiol. 1992; 13 (5): 1343–1352.
[29] Lee SR, et al. Posterior fossa hemangioblastoma: MR imaging. Radiology. 1989; 171: 463–468.
[30] Lonser RR, et al. Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol. 2005; 58: 392–399.
[31] Maiuri F, et al. Cysts with mural nodules in the cerebral hemispheres. Neurosurgery. 1988; 22: 703.
[32] Padhi, et al. A 10 year retrospective study of hemangioblastoma of the CNS with reference to von Hippel Lindau disease. J clinical neuroscience. 2011; 18: 939–944.
[33] Slater A, et al. The natural history of cerebellar hemangioblastoma in von Hippel-Lindau disease. AJNR Am J Neuroradiol. 2003; 24 (8): 1570–1574.
[34] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. doi: 10.1136/bmj.n71.
[35] *Tse JY, Wong JH, Lo KW, Poon WS, Huang DP, Ng HK. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Am J Clin Pathol 1997; 107: 459-66.
[36] Yin X, Duan H, Yi Z, Li C, Lu R, Li L. Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the Surveillance, Epidemiology, and End Results Database. Front Oncol 2020; 10: 570103.
[37] Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol 2021; 23: iii1-105.
[38] Constans JP, Meder F, Maiuri F, Donzelli R, Spaziante R, de Divitiis E. Posterior fossa hemangioblastomas. Surg Neurol 1986; 25: 269-75.
[39] Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 2001; 48: 55-62.
[40] Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet 2003; 361: 2059-67.
[41] Jagannathan J, Lonser RR, Smith R, DeVroom HL, Oldfield EH. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2008; 108: 210-22.
[42] Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI. Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery 2001; 49: 321-7.
[43] Chu BC, Terae S, Hida K, Furukawa M, Abe S, Miyasaka K. MR findings in spinal hemangioblastoma: correlation with symptoms and with angiographic and surgical findings. AJNR Am J Neuroradiology 2001; 22: 206-17.
[44] Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural his tory of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurgery 2003; 98: 82-94.
[45] Ene CI, Morton RP, Ferreira M Jr, Sekhar LN, Kim LJ. Spontaneous hemorrhage from central nervous system hemangioblastomas. World Neurosurgery 2015; 83: 1180.
[46] de San Pedro JR, Rodriguez FA, Niguez BF, et al. massive hemorrhage in hemangioblastomas literature review. Neurosurgery Rev 2010; 33: 11-26.
[47] Rebecca A. Yoda, Patrick J. Cimino, et al. Neuropathologic features of central nervous system hemangioblastoma. Journal of Pathology and Translational Medicine 2022; 56: 115-125.
[48] Rachinger J, Buslei R, Prell J, Strauss C. Solid haemangioblastomas of the CNS: a review of 17 consecutive cases. Neurosurg Rev. (2009) 32: 37–47. doi: 10.1007/s10143-008-0166-0.
[49] Bründl E, Schödel P, Ullrich OW, Brawanski A, Schebesch KM. Surgical resection of sporadic and hereditary hemangioblastoma: our 10-year experience and a literature review. Surg Neurol Int. (2014) 5: 138. doi: 10.4103/2152-7806.141469.
[50] Yousef A, Rutkowski MJ, Yalcin CE, Eren OC, Caliskan I, Tihan T. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences. J Neurooncol. (2019) 143: 547–52. doi: 10.1007/s11060-019-03189-w.
[51] Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, et al. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. (2014) 120: 1055–62. doi: 10.3171/2014.1. Jns131431.
[52] Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg. (2006) 105: 248–55. doi: 10. 3171/jns.2006.105.2.248.
[53] Dornbos D III, Kim HJ, Butman JA, Lonser RR. Review of the neurological implications of von Hippel-Lindau disease. JAMA Neurol. (2018) 75: 620–7. doi: 10.1001/jamaneurol.2017.4469.
[54] Weil RJ, Lonser RR, DeVroom HL, Wanebo JE, Oldfield EH. Surgical management of brainstem hemangioblastomas in patients with von Hippel- Lindau disease. J Neurosurg. (2003) 98: 95–105. doi: 10.3171/jns.2003.98.1.0095.
[55] Bridges KJ, Jaboin JJ, Kubicky CD, Than KD. Stereotactic radiosurgery versus surgical resection for spinal hemangioblastoma: a systematic review. Clin Neurol Neurosurg. (2017) 154: 59–66. doi: 10.1016/j.clineuro.2017.01.012.
[56] Pan J, Jabarkheel R, Huang Y, Ho A, Chang SD. Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and metaanalysis. J Neurooncol. (2018) 137: 11–22. doi: 10.1007/s11060-017-2697-0.
[57] Fukuda M, Takao T, Hiraishi T, Yoshimura J, Yajima N, Saito A, et al. Clinical factors predicting outcomes after surgical resection for sporadic cerebellar hemangioblastomas. World Neurosurg. (2014) 82: 815–21. doi: 10.1016/j.wneu. 2014.06.018.
[58] Ordookhanian C, Kaloostian PE, Ghostine SS, Spiess PE, Etame AB. Management strategies and outcomes for VHL-related craniospinal hemangioblastomas. J Kidney Cancer VHL. (2017) 4: 37–44. doi: 10.15586/jkcvhl.2017.90.
[59] Kanno H, Kobayashi N, Nakanowatari S. Pathological and clinical features and management of central nervous system hemangioblastomas in von Hippel- Lindau disease. J Kidney Cancer VHL. (2014) 1: 46–55. doi: 10.15586/jkcvhl.2014.12.
[60] Mountain JL, Risch N. Assessing genetic contributions to phenotypic differences among ‘racial’ and ‘ethnic’ groups. Nat Genet. (2004) 36 (11 Suppl): S48–53. doi: 10.1038/ng1456.
[61] Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. (2003) 348: 1170–5. doi: 10.1056/NEJMsb025007.
[62] Kirsch-Volders M, Bonassi S, Herceg Z, Hirvonen A, Möller L, Phillips DH. Gender-related differences in response to mutagens and carcinogens. Mutagenesis. (2010) 25: 213–21. doi: 10.1093/mutage/geq008.
[63] Butman JA, Linehan WM, Lonser RR. Neurologic manifestations of von Hippel-Lindau disease. JAMA. (2008) 300: 1334–42. doi: 10.1001/jama.300.11.1334.
[64] Xiangdong Yin, Hongzhou Duan, Zhiqiang Yi, Chunwei Li, Runchun Lu and Liang Li. Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database. (2020) 10: 570103. doi: 10.3389/fonc.2020.570103.
Cite This Article
  • APA Style

    Ali Reza Arabestanino, Arman Ai, Sina Naghibi Irvani, Mahdiar Mahmoodi, Mohammad Matin Chaboki, et al. (2023). Headache in Hemangioblastomas: A Histopathology and Structural. Pharmaceutical Science and Technology, 7(1), 5-12. https://doi.org/10.11648/j.pst.20230701.12

    Copy | Download

    ACS Style

    Ali Reza Arabestanino; Arman Ai; Sina Naghibi Irvani; Mahdiar Mahmoodi; Mohammad Matin Chaboki, et al. Headache in Hemangioblastomas: A Histopathology and Structural. Pharm. Sci. Technol. 2023, 7(1), 5-12. doi: 10.11648/j.pst.20230701.12

    Copy | Download

    AMA Style

    Ali Reza Arabestanino, Arman Ai, Sina Naghibi Irvani, Mahdiar Mahmoodi, Mohammad Matin Chaboki, et al. Headache in Hemangioblastomas: A Histopathology and Structural. Pharm Sci Technol. 2023;7(1):5-12. doi: 10.11648/j.pst.20230701.12

    Copy | Download

  • @article{10.11648/j.pst.20230701.12,
      author = {Ali Reza Arabestanino and Arman Ai and Sina Naghibi Irvani and Mahdiar Mahmoodi and Mohammad Matin Chaboki and Bita Dinarvand},
      title = {Headache in Hemangioblastomas: A Histopathology and Structural},
      journal = {Pharmaceutical Science and Technology},
      volume = {7},
      number = {1},
      pages = {5-12},
      doi = {10.11648/j.pst.20230701.12},
      url = {https://doi.org/10.11648/j.pst.20230701.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.pst.20230701.12},
      abstract = {Background: To determine the efficacy of treatment of central nervous system (CNS) hemangioblastomas in von Hippel-Lindau disease (VHL), long-term outcomes in patients with hemangioblastoma and VHL variant were accepted. Hemangioblastoma is rare, histological origin. Highly vascularized tumors that can be found throughout the neuraxis but are mainly located in the cerebellum and in the spinal cord. The most common primary tumor of the posterior fossa in adults. Hemangioblastomas may also occur within the spine. Material and Methods: This meta-analysis was performed to evaluate headaches in Hemangioblastoma (HBL) tumors structurally and separately based on randomized controlled trial studies. Electronic databases (PubMed, MEDLINE, Embase, and Cochrane Library) were searched for randomized and controlled trial studies that searched for the results of treatment of brain tumors (Hemangioblastoma type) and headache in Hemangioblastoma (HBL) tumors. Result: This meta-analysis was performed using Review Manager (Rev Man) software (version 5.2) provided by Cochrane Collaboration. The data used were hazard ratios with 95% confidence intervals calculated for time-to-event data extracted from survival curves and local tumor control rate curves. A consecutive series of patients with hemangioblastomas on between 2010 and 2020 by the senior author (A. AN) is Reviewed. Conclusion: Adequate knowledge of the treatment and correct use of microsurgical techniques allows complete resection of these tumors with minimal complications and maximum functional improvement. The result appears to be directly related to the preoperative condition.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Headache in Hemangioblastomas: A Histopathology and Structural
    AU  - Ali Reza Arabestanino
    AU  - Arman Ai
    AU  - Sina Naghibi Irvani
    AU  - Mahdiar Mahmoodi
    AU  - Mohammad Matin Chaboki
    AU  - Bita Dinarvand
    Y1  - 2023/07/06
    PY  - 2023
    N1  - https://doi.org/10.11648/j.pst.20230701.12
    DO  - 10.11648/j.pst.20230701.12
    T2  - Pharmaceutical Science and Technology
    JF  - Pharmaceutical Science and Technology
    JO  - Pharmaceutical Science and Technology
    SP  - 5
    EP  - 12
    PB  - Science Publishing Group
    SN  - 2640-4540
    UR  - https://doi.org/10.11648/j.pst.20230701.12
    AB  - Background: To determine the efficacy of treatment of central nervous system (CNS) hemangioblastomas in von Hippel-Lindau disease (VHL), long-term outcomes in patients with hemangioblastoma and VHL variant were accepted. Hemangioblastoma is rare, histological origin. Highly vascularized tumors that can be found throughout the neuraxis but are mainly located in the cerebellum and in the spinal cord. The most common primary tumor of the posterior fossa in adults. Hemangioblastomas may also occur within the spine. Material and Methods: This meta-analysis was performed to evaluate headaches in Hemangioblastoma (HBL) tumors structurally and separately based on randomized controlled trial studies. Electronic databases (PubMed, MEDLINE, Embase, and Cochrane Library) were searched for randomized and controlled trial studies that searched for the results of treatment of brain tumors (Hemangioblastoma type) and headache in Hemangioblastoma (HBL) tumors. Result: This meta-analysis was performed using Review Manager (Rev Man) software (version 5.2) provided by Cochrane Collaboration. The data used were hazard ratios with 95% confidence intervals calculated for time-to-event data extracted from survival curves and local tumor control rate curves. A consecutive series of patients with hemangioblastomas on between 2010 and 2020 by the senior author (A. AN) is Reviewed. Conclusion: Adequate knowledge of the treatment and correct use of microsurgical techniques allows complete resection of these tumors with minimal complications and maximum functional improvement. The result appears to be directly related to the preoperative condition.
    VL  - 7
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Departmant Factual of Medicine, Harvard Medical School, Boston, Unite State; Departmant Factual of Medicine, Sheikh Khalifa Medical Centre, Abu Dhabi, Emirate; Departmant Factual of Medicine, Shahid Beheshti University Medical of Science, Tehran, Iran

  • Departmant Factual of Medicine, Tehran University Medical of Science, Tehran, Iran

  • Departmant Factual of Medicine, Harvard Medical School, Boston, Unite State; Departmant Factual of Medicine, Shahid Beheshti University Medical of Science, Tehran, Iran

  • Departmant Factual of Medicine, Qom University Medical of Science, Qom, Iran

  • Departmant Factual of Medicine, Qom University Medical of Science, Qom, Iran

  • Departmant Factual of Medicine, Iran University Medical of Science, Tehran, Iran

  • Sections